Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.
Cathie Wood
Disruptive Innovation Lead
Isolated
View
Constructive — the work is worth continuing, not an order. On MELI, I care whether the decade capital flow still funds this vehicle — revenue YoY 34.3%, revenue $20.3B. Region: LatAm.
Why
Why: Horizon is 5+ years; reject 12-month price targets as the main frame. If the industry is not on the decade map, I pass without a speech. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Business dig: MELI must still sit inside a funded decade theme — not a tourist ticker. On file: revenue $20.3B; revenue YoY 34.3%.
Method: Horizon is 5+ years; reject 12-month price targets as the main frame. Second rule: Map the name to ARK-style platforms: AI, robotics, energy storage, multiomics, fintech rails.
Variant view: the tape often prices the theme; this seat prices whether MELI is the vehicle.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the era is right and the vehicle is wrong — or the era has already been bid. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
revenue CAGR vs category S-curve
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Philippe Laffont
Tech Commercialization Validator
Isolated
View
Constructive — the work is worth continuing, not an order. On MELI, I care whether the decade capital flow still funds this vehicle — revenue YoY 34.3%, revenue $20.3B. Region: LatAm.
Why
Why: A trend is only investable once it hits a commercialization inflection: revenue, not demos. If the industry is not on the decade map, I pass without a speech. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Business dig: MELI must still sit inside a funded decade theme — not a tourist ticker. On file: revenue $20.3B; revenue YoY 34.3%.
Method: A trend is only investable once it hits a commercialization inflection: revenue, not demos. Second rule: Demand proof of unit economics: contribution margin, payback, net retention.
Variant view: the tape often prices the theme; this seat prices whether MELI is the vehicle.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the era is right and the vehicle is wrong — or the era has already been bid. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
YoY revenue inflection
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Ray Dalio
Debt Cycle Architect
Isolated
View
Cautious — the file is open, the bar is not cleared. MELI sits on the thermometer before any multiple debate — Late Expansion at 62. Region: LatAm.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On MELI: On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
policy rate vs inflation
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Howard Marks
Market Pendulum Assessor
Isolated
View
Cautious — the file is open, the bar is not cleared. MELI sits on the thermometer before any multiple debate — Late Expansion at 62. Region: LatAm.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On MELI: On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
credit spreads vs history
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
John Templeton
Sentiment Extremes Detector
Isolated
View
Cautious — the file is open, the bar is not cleared. MELI sits on the thermometer before any multiple debate — Late Expansion at 62. Region: LatAm.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On MELI: On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
drawdown from peak
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
George Soros
Reflexivity Tester
Isolated
View
Cautious — the file is open, the bar is not cleared. MELI sits on the thermometer before any multiple debate — Late Expansion at 62. Region: LatAm.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On MELI: On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Reflexivity Tester
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
John Paulson
Credit Quality & Systemic Risk Monitor
Isolated
View
Cautious — the file is open, the bar is not cleared. MELI sits on the thermometer before any multiple debate — Late Expansion at 62. Region: LatAm.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On MELI: On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Credit Quality & Systemic Risk Monitor
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Paul Tudor Jones
Macro Cycle Inflection Confirmer
Isolated
View
Cautious — the file is open, the bar is not cleared. MELI sits on the thermometer before any multiple debate — Late Expansion at 62. Region: LatAm.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On MELI: On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Macro Cycle Inflection Confirmer
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Benjamin Graham
Margin of Safety Guardian
Isolated
View
Constructive — the work is worth continuing, not an order. Owner test on MELI: P/E 48.4, P/B 14.32, ROE 29.6%, net income $2.0B. Region: LatAm.
Why
Why: Teacherly, quantitative, unsentimental. I want a business I would own in full. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Owner earnings lens on MELI. Teacherly, quantitative, unsentimental. Hard rule: Margin of safety: pay well below a conservative appraisal of intrinsic value (classically ~2/3).
Numbers on file: P/E 48.4; P/B 14.32; ROE 29.6%; net income $2.0B; revenue YoY 34.3%. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
P/B
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Warren Buffett
Moat & Management Final Review
Isolated
View
Constructive — the work is worth continuing, not an order. Owner test on MELI: P/E 48.4, P/B 14.32, ROE 29.6%, net income $2.0B. Region: LatAm.
Why
Why: Plain Midwest English, folksy metaphors, long-horizon. I want a business I would own in full. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Owner earnings lens on MELI. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass.
Numbers on file: P/E 48.4; P/B 14.32; ROE 29.6%; net income $2.0B; revenue YoY 34.3%. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
ROIC / ROE durability
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Seth Klarman
Distressed & Special Situations
Isolated
View
Constructive — the work is worth continuing, not an order. Owner test on MELI: P/E 48.4, P/B 14.32, ROE 29.6%, net income $2.0B. Region: LatAm.
Why
Why: Cautious, cash-heavy, academic-practitioner. I want a business I would own in full. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Owner earnings lens on MELI. Cautious, cash-heavy, academic-practitioner. Hard rule: Margin of safety is a philosophy, not a slogan — downside first.
Numbers on file: P/E 48.4; P/B 14.32; ROE 29.6%; net income $2.0B; revenue YoY 34.3%. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
downside to liquidation or conservative FCF
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Chuck Akre
Compounding Machine Identifier
Isolated
View
Constructive — the work is worth continuing, not an order. Owner test on MELI: P/E 48.4, P/B 14.32, ROE 29.6%, net income $2.0B. Region: LatAm.
Why
Why: Contemporary. I want a business I would own in full. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Owner earnings lens on MELI. Contemporary. Hard rule: Three-legged stool: business model / reinvestment / management. ~13%+ compounded..
Numbers on file: P/E 48.4; P/B 14.32; ROE 29.6%; net income $2.0B; revenue YoY 34.3%. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Compounding Machine Identifier
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Duan Yongping
Business Model Clarity Checker
Isolated
View
Constructive — the work is worth continuing, not an order. Owner test on MELI: P/E 48.4, P/B 14.32, ROE 29.6%, net income $2.0B. Region: LatAm.
Why
Why: Plain Chinese-internet elder-brother tone: 本分, 买股票就是买公司. I want a business I would own in full. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Owner earnings lens on MELI. Plain Chinese-internet elder-brother tone: 本分, 买股票就是买公司. Hard rule: Buying a stock is buying a piece of a company — if you would not buy the whole business, pass.
Numbers on file: P/E 48.4; P/B 14.32; ROE 29.6%; net income $2.0B; revenue YoY 34.3%. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
business model in one sentence
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Li Lu
Circle of Competence + Civilization Cycle
Isolated
View
Constructive — the work is worth continuing, not an order. Owner test on MELI: P/E 48.4, P/B 14.32, ROE 29.6%, net income $2.0B. Region: LatAm.
Why
Why: Contemporary. I want a business I would own in full. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Owner earnings lens on MELI. Contemporary. Hard rule: Himalaya Capital. Munger family asset manager. Chinese assets expert..
Numbers on file: P/E 48.4; P/B 14.32; ROE 29.6%; net income $2.0B; revenue YoY 34.3%. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Circle of Competence + Civilization Cycle
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Peter Lynch
Ten-Bagger Hunter
Isolated
View
Constructive — the work is worth continuing, not an order. Classify MELI before cheering growth. revenue YoY 34.3%. P/E 48.4. Region: LatAm.
Why
Why: Six-category company classification system.. Unclassified growth is a narrative. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Classify before multiple. Six-category company classification system..
revenue YoY 34.3%. P/E 48.4. revenue $20.3B. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: mis-classification — a cyclical labeled a compounder. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
EPS growth
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Bill Ackman
Quality Giant + Activist Catalyst
Isolated
View
Constructive — the work is worth continuing, not an order. Classify MELI before cheering growth. revenue YoY 34.3%. P/E 48.4. Region: LatAm.
Why
Why: Made $2.6B shorting COVID in 2020; famous Herbalife battle with Icahn.. Unclassified growth is a narrative. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Classify before multiple. Made $2.6B shorting COVID in 2020; famous Herbalife battle with Icahn..
revenue YoY 34.3%. P/E 48.4. revenue $20.3B. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: mis-classification — a cyclical labeled a compounder. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Quality Giant + Activist Catalyst
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Joel Greenblatt
Magic Formula + Special Situations
Isolated
View
Constructive — the work is worth continuing, not an order. Classify MELI before cheering growth. revenue YoY 34.3%. P/E 48.4. Region: LatAm.
Why
Why: Author of The Little Book That Beats the Market.. Unclassified growth is a narrative. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Classify before multiple. Author of The Little Book That Beats the Market..
revenue YoY 34.3%. P/E 48.4. revenue $20.3B. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: mis-classification — a cyclical labeled a compounder. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
EBIT/EV
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
David Einhorn
Financial Statement Quality Inquisitor
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Red team only: interrogate, do not pitch a long Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Red team only: interrogate, do not pitch a long.
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
receivables vs revenue
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Michael Burry
Extreme Contrarian: Hidden Assumptions
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Red team: dismantle the valuation model's hidden assumptions Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Red team: dismantle the valuation model's hidden assumptions.
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
embedded growth rate in the multiple
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Carl Icahn
Governance & Self-Dealing Interrogator
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Icahn Enterprises. Corporate governance and self-dealing scrutiny. Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Icahn Enterprises. Corporate governance and self-dealing scrutiny..
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Governance & Self-Dealing Interrogator
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Dan Loeb
Narrative & Catalyst Authenticity Checker
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Third Point. Sharp shareholder letters + event-driven analysis. Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Third Point. Sharp shareholder letters + event-driven analysis..
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Narrative & Catalyst Authenticity Checker
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Paul Singer
Tail Risk & Legal/Contract Vulnerability
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Elliott Management. Activist and distressed debt. Tail risk and legal vulnerability. Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Elliott Management. Activist and distressed debt. Tail risk and legal vulnerability..
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Tail Risk & Legal/Contract Vulnerability
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Michael Steinhardt
Consensus Divergence Tester
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Hedge fund pioneer. 30-year ~24% annualized. Where does this thesis diverge from consensus? Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Hedge fund pioneer. 30-year ~24% annualized. Where does this thesis diverge from consensus?.
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Consensus Divergence Tester
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Stanley Druckenmiller
Conviction Concentration Stress Test
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Duquesne Capital. 30+ year ~30% annualized. "If you had one shot, would you bet big?" Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Duquesne Capital. 30+ year ~30% annualized. "If you had one shot, would you bet big?".
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Conviction Concentration Stress Test
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Charlie Munger
Inversion Thinking Arbiter
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert MELI first. What has to be false for the bull to die? Region: LatAm.
Why
Why: kill-shot seat. Invert: how would this thesis get killed? List the kill-shots before the romance Footnotes beat stories. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Invert MELI. Invert: how would this thesis get killed? List the kill-shots before the romance.
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Name what must be true for the bull: earnings quality, leverage (1.36), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
incentive structure
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
William O'Neil
CANSLIM Entry Point
Isolated
View
Constructive — the work is worth continuing, not an order. No trigger, no implied entry on MELI — quality seats do not move this pencil. Region: LatAm.
Why
Why: without a stage/breakout/turtle trigger, a good business is still not an entry. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Trigger or nothing. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Stage / breakout / turtle — pick the method this seat uses. A constructive quality seat elsewhere does not create an entry here.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: entering because the committee liked the business. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
quarterly EPS acceleration
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Mark Minervini
SEPA Stage-2 Confirmation
Isolated
View
Constructive — the work is worth continuing, not an order. No trigger, no implied entry on MELI — quality seats do not move this pencil. Region: LatAm.
Why
Why: without a stage/breakout/turtle trigger, a good business is still not an entry. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Trigger or nothing. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Stage / breakout / turtle — pick the method this seat uses. A constructive quality seat elsewhere does not create an entry here.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: entering because the committee liked the business. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
SEPA Stage-2 Confirmation
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Steve Cohen
Short-Term Signal & Tape Reading
Isolated
View
Constructive — the work is worth continuing, not an order. No trigger, no implied entry on MELI — quality seats do not move this pencil. Region: LatAm.
Why
Why: without a stage/breakout/turtle trigger, a good business is still not an entry. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
Trigger or nothing. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
Stage / breakout / turtle — pick the method this seat uses. A constructive quality seat elsewhere does not create an entry here.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: entering because the committee liked the business. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
Short-Term Signal & Tape Reading
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
Ed Thorp
Kelly Criterion Position Sizing
Isolated
View
Constructive — the work is worth continuing, not an order. MELI is a distribution. P/E 48.4; P/B 14.32. Thin sample → smaller size. Region: LatAm.
Why
Why: if edge is not measurable, Kelly ceiling collapses. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash..
Analysis
Question: “Research MELI as a US-listed emerging-market name.”.
MELI is a return distribution, not a feeling. On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
P/E 48.4; P/B 14.32. If sample is thin or correlations hid risk, size shrinks. Kelly is a ceiling.
Underwrite frame: Worth further homework. EM overlay: LatAm · Commerce + fintech. A compounder in under-banked markets. Still a growth test, not a cigar butt. Kill-shot unique to this listing: Credit losses in the fintech arm overwhelm marketplace cash.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: overfitting a short sample or sizing as if variance were known. EM-specific: Credit losses in the fintech arm overwhelm marketplace cash.
Looks at
whether a statistical edge is even claimed
On file: 10-K FY FY2025; revenue $20.3B; revenue YoY 34.3%; net income $2.0B; ROE 29.6%; LT debt/equity 1.36; P/E 48.4; P/B 14.3; P/S 4.8; price $1906.24 cached.
This seat flips if: Credit losses in the fintech arm overwhelm marketplace cash..
